Edgewise Therapeutics, Inc. held its Annual Meeting of stockholders on June 4, 2026.
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001104659-26-071011
- Reports shareholder vote results (5.07)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Innoviva INVA public float $1.3B, Jun 30, 2025
- Mannkind MNKD public float $1.1B, Jun 30, 2025
- Schrodinger SDGR public float $1.1B, Jun 30, 2025
- Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
- Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025
